Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

DSM to Acquire Twilmij B.V. to Strengthen Position in Animal Nutrition & Health

Royal DSM
Posted on: 25 Sep 17

HEERLEN, Netherlands, September 22, 2017 /PRNewswire/ --

Royal DSM, a global science-based company active in health, nutrition and materials, announces the acquisition of Twilmij B.V. ("Twilmij"), a well-established Dutch nutritional solutions company in the animal feed sector.  

DSM's strategy in Animal Nutrition & Health is to offer tailor-made solutions to its customers leveraging its product portfolio and innovation capabilities. With the acquisition of Twilmij, it will further strengthen its foothold in the Northwest-European markets. The geographic location in the middle of the Netherlands and close to the German border brings DSM closer to its customers and allows it to further improve its service levels.

Since its inception in 1963, Twilmij has successfully grown its business to net sales of approximately €70 million (50,000 tons of premix production) in 2016. Twilmij is recognized by its customers and other stakeholders as an outstanding partner due to its excellent nutritional services, speed, and agility. The acquisition also includes Twilmij's affiliated company Kwalipak B.V. which offers specialty small-pack solutions for specific applications for the feed industry. Twilmij's core values, customer portfolio and solutions are a perfect fit with DSM's ambitions in the animal nutrition & health market. Financial details will not be disclosed at this time. Subject to customary conditions, the transaction is expected to close in the next two to three months.

DSM - Bright Science. Brighter Living.™ 

Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in life sciences and materials sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders simultaneously. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 25,000 employees. The company is listed on Euronext Amsterdam. More information can be found at http://www.dsm.com.

Forward-looking statements

This press release may contain forward-looking statements with respect to DSM's future (financial) performance and position. Such statements are based on current expectations, estimates and projections of DSM and information currently available to the company. DSM cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. DSM has no obligation to update the statements contained in this press release, unless required by law. The English language version of the press release is leading.

Royal DSM

media.contacts@dsm.com

http://www.dsm.com

For more information:
DSM Corporate Communications
Herman Betten
tel. +31-(0)-45-5782017        
e-mail media.contacts@dsm.com

DSM Investor Relations
Dave Huizing
tel. +31-(0)-45-5782864
e-mail investor.relations@dsm.com 

PDF - http://mma.prnewswire.com/media/559682/Royal_DSM_to_acquire_Twilmij_B_V.pdf

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 25/09/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.